Johnson & Johnson announced a deal with Japanese Ci:z Holdings for the purchase of all its outstanding shares for 230 billion yen. Jonson & Johnson, through its subsidiary, already owns a 19.9% stake in the Japanese company. Under the terms of the deal, the American company will pay 5,900 yen per Ci:z share, taking into account the 55% premium compared to the price of the shares at the end of trading on Tuesday. Having gained control over the popular brands of the Japanese company, Johnson & Johnson expects to strengthen its position in the field of innovation in the international market.
European shares traded lower earlier on Thursday after underwhelming earnings reports dampened a U.S. Fed vow to continue rolling out stimulus plans in a bid to soften the economic blow of the COVID-19 pandemic. The pan-European STOXX lost ...
Indonesia on Wednesday rolled out a 100 trillion Rupiah ($6.92 billion) loan guarantee scheme for prioritized businesses to keep them afloat as the COVID-19 situation continued to worsen around the world, the country’s finance minister ...
Britain on Wednesday signed a supply deal for up to 60 million doses of a possible COVID-19 vaccine that is being developed by pharmaceutical companies GlaxoSmithKline (GSK) and Sanofi. The financial details of the agreement were not disclosed. However, ...
European stocks traded slightly higher on Tuesday ahead of a U.S. decision to roll out additional stimulus plans despite the underwhelming quarterly earnings reports from the luxury goods market. The pan-European STOXX index inched higher ...
Samsung Electronics’ shares joined TSMC, its competitor, as both extended gains on Tuesday. This was mainly from upbeat expectations that Intel Corp’s plan of outsourcing more chip producers would favor the chipmakers. Shares of ...